Nanobiotix annual operating margin
2018
2019
2020
2021
2022
2023
2025
Nanobiotix Operating Margin Growth & History (NANO)
Nanobiotix's operating margin was −36.49% for fiscal 2025.
View full Nanobiotix company overviewNanobiotix annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −36.49% | — |
| 2023 | 2023-12-31 | −89.09% | +888.76 pp |
| 2022 | 2022-12-31 | −977.85% | +1008.51 pp |
| 2021 | 2021-12-31 | −1,986.36% | −536.20 pp |
| 2020 | 2020-12-31 | −1,450.16% | +390.81 pp |
| 2019 | 2019-12-31 | −1,840.97% | −976.73 pp |
| 2018 | 2018-12-31 | −864.24% | — |
Nanobiotix operating margin trends
Over the last five fiscal years, Nanobiotix's operating margin increased from −1,450.16% to −36.49%, a change of +1413.66 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nanobiotix source filings ↗Community posts
Nanobiotix reports final melanoma cohort results for radioenhancer combination
Nanobiotix ($NANO) reported updated Phase 1 results in 24 heavily pretreated patients with advanced cutaneous melanoma resistant to anti-PD-1 therapy. Its JNJ-1900, also called NBTXR3, was injected into a tumor before radiotherapy and subse ...
